NASDAQ:CHRS | Free Cash Flow | Coherus Oncology, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$57.89M
2025-12-31-$19.72M
2025-03-31-$25.83M
2024-12-31$28.61M
2024-03-31-$46.77M
2023-12-31-$12.94M$34,000.00-$12.97M
2023-03-31-$68.73M$152,000.00-$68.88M
2022-12-31-$99.95M$87,000.00-$100.04M
2022-03-31-$54.05M$615,000.00-$54.66M
2021-12-31-$52.32M$468,000.00-$52.79M
2021-03-31$1.37M$145,000.00$1.22M
2020-12-31$33.12M$952,000.00$32.17M331.40%
2020-03-31$13.48M$1.78M$11.69M32.87%
2019-12-31$17.71M$387,000.00$17.32M44.16%
2019-03-31-$56.98M$335,000.00-$57.32M
2018-12-31-$47.36M$214,000.00-$47.58M
2018-03-31-$33.58M$81,000.00-$33.67M
2017-12-31-$29.92M$109,000.00-$30.03M
2017-03-31-$73.28M$1.69M-$74.97M
2016-12-31-$86.89M$3.57M-$90.46M
2016-03-31-$76.32M$2.15M-$78.46M
2015-12-31$5.57M$1.44M$4.12M
2015-03-31-$33.06M$1.31M-$34.38M
2014-12-31-$33.29M$489,000.00-$33.77M
2014-03-31$14.75M$260,000.00$14.49M
2013-12-31$4.99M$148,000.00$4.84M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$138.51M
2024-12-31-$20.44M
2023-12-31-$174.88M$286,000.00-$175.17M
2022-12-31-$241.12M$2.04M-$243.16M
2021-12-31-$37.43M$1.29M-$38.72M
2020-12-31$154.15M$7.23M$146.91M111.09%
2019-12-31$28.36M$1.82M$26.53M29.54%
2018-12-31-$159.27M$789,000.00-$160.06M
2017-12-31-$200.29M$4.57M-$204.86M
2016-12-31-$252.55M$6.52M-$259.06M
2015-12-31-$107.99M$6.16M-$114.15M
2014-12-31-$23.93M$2.85M-$26.78M
2013-12-31$15.42M$373,000.00$15.05M
2012-12-31-$18.25M$1.78M-$20.03M